LeMaitre Vascular, Inc. to Issue Quarterly Dividend of $0.20 (NASDAQ:LMAT)

Key Points

• LeMaitre Vascular, Inc. declared a quarterly dividend of $0.20 per share, with a yield of 0.9%, payable on September 4th to stockholders of record on August 21st.
• The company's quarterly earnings report revealed an earnings per share of $0.60, exceeding estimates, with a 15% year-over-year revenue increase.
• LeMaitre Vascular's stock rose by 8.9%, closing at $93.23, with strong trading volume significantly above its average.

LeMaitre Vascular, Inc. (NASDAQ:LMAT - Get Free Report) declared a quarterly dividend on Wednesday, July 30th, Wall Street Journal reports. Investors of record on Thursday, August 21st will be paid a dividend of 0.20 per share by the medical instruments supplier on Thursday, September 4th. This represents a c) annualized dividend and a yield of 0.9%. The ex-dividend date of this dividend is Thursday, August 21st.

LeMaitre Vascular has a dividend payout ratio of 33.6% indicating that its dividend is sufficiently covered by earnings. Equities research analysts expect LeMaitre Vascular to earn $2.17 per share next year, which means the company should continue to be able to cover its $0.80 annual dividend with an expected future payout ratio of 36.9%.

LeMaitre Vascular Stock Down 2.1%

NASDAQ LMAT traded down $1.98 during trading hours on Friday, hitting $92.28. The company's stock had a trading volume of 149,596 shares, compared to its average volume of 149,416. LeMaitre Vascular has a 52 week low of $71.42 and a 52 week high of $109.58. The company has a market capitalization of $2.09 billion, a PE ratio of 44.80, a price-to-earnings-growth ratio of 2.37 and a beta of 0.79. The company has a current ratio of 13.96, a quick ratio of 11.74 and a debt-to-equity ratio of 0.46. The company's 50-day simple moving average is $83.35 and its two-hundred day simple moving average is $86.50.

LeMaitre Vascular (NASDAQ:LMAT - Get Free Report) last announced its quarterly earnings results on Tuesday, August 5th. The medical instruments supplier reported $0.60 earnings per share for the quarter, beating the consensus estimate of $0.57 by $0.03. LeMaitre Vascular had a net margin of 20.08% and a return on equity of 13.67%. The business had revenue of $63.15 million for the quarter, compared to analysts' expectations of $62.48 million. During the same quarter last year, the firm earned $0.52 EPS. The firm's revenue for the quarter was up 15.0% compared to the same quarter last year. Research analysts anticipate that LeMaitre Vascular will post 1.94 EPS for the current fiscal year.

About LeMaitre Vascular

LeMaitre Vascular, Inc develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature.